CSIMarket
 


Enovis Corporation  (ENOV)
Other Ticker:  
 

Enovis's Long Term Debt to Equity

ENOV's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


Due to net new long-term borrowings of 18.02%, Long Term Debt to Equity fell to 0.14, below the Enovis's average Long Term Debt to Equity.

Within Medical Equipment & Supplies industry in the forth quarter 2023, 14 other companies have achieved lower Long Term Debt to Equity than Enovis in the IV Quarter 2023. While Long Term Debt to Equity total ranking has improved so far in the forth quarter 2023 to 337, from total ranking in the third quarter 2023 at 455 .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt ENOV´s has?
What is the structure of ENOV´s Equity?


ENOV Long Term Debt to Equity (Dec 31 2023)
IV. Quarter
(Sep 29 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -0.84 % 0.98 % -1.17 % -26.09 % -25.72 %
Y / Y Long Term Debt Change 1065.41 % - - -86.29 % -97.57 %
Long Term Debt to Equity MRQ 0.14 0.11 0.12 0.08 0.01
ENOV's Total Ranking # 337 # 455 # 168 # 117 # 128
Seq. Equity Change -0.61 % -0.26 % 0.16 % -0.13 % 1.22 %
Seq. Long Term Debt Change 18.02 % -1.25 % 40.35 % 612.5 % -



Long Term Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 15
Healthcare Sector # 43
Overall Market # 337


Long Term Debt to Equity Statistics
High Average Low
1.28 0.49 0.01
(Sep 27 2019)   (Dec 31 2022)




Financial Statements
Enovis's Equity $ 3,421 Millions Visit ENOV's Balance sheet
Enovis's Long Term Debt $ 466 Millions Visit ENOV's Balance sheet
Source of ENOV's Sales Visit ENOV's Sales by Geography


Cumulative Enovis's Long Term Debt to Equity

ENOV's Long Term Debt to Equity for the trailling 12 Months

ENOV Long Term Debt to Equity

(Dec 31 2023)
IV. Quarter
(Sep 29 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -0.84 % 0.98 % -1.17 % -26.09 % -25.72 %
Y / Y Long Term Debt TTM Growth 1065.41 % - - -86.29 % -97.57 %
Long Term Debt to Equity TTM 0.11 0.08 0.05 0.02 0.14
Total Ranking TTM # 308 # 9 # 588 # 49 # 46
Seq. Equity TTM Growth -0.61 % -0.26 % 0.16 % -0.13 % 1.22 %
Seq. Long Term Debt TTM Growth 18.02 % -1.25 % 40.35 % 612.5 % -


On the trailing twelve months basis Due to the net new long-term borrowings of 18.02% during the trailing twelve months finishing in the IV Quarter 2023, cumulativeLong Term Debt to Equity improved to 0.11, below the Enovis's average Long Term Debt to Equity.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 16, during the past 12 months, other companies have achieved lower Long Term Debt to Equity than Enovis. While Long Term Debt to Equity total ranking has deteriorated during the twelve months ending in the IV Quarter 2023, compared to the prior period, from 9 to 308.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt ENOV´s has?
What is the structure of ENOV´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 17
Healthcare Sector # 47
Within the Market # 308


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
1.06 0.45 0.02
(Dec 31 2019)   (Mar 31 2023)




Companies with similar Long Term Debt to Equity in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Long Term Debt to EquityDec 31 2023 MRQ Long Term DebtDec 31 2023 MRQ Equity
Mimedx Group Inc   0.34 $ 48.099  Millions$ 142.717  Millions
Envista Holdings Corporation  0.33 $ 1,398.100  Millions$ 4,173.900  Millions
Pulmonx Corporation  0.30 $ 35.089  Millions$ 118.315  Millions
Resmed Inc   0.27 $ 1,216.769  Millions$ 4,481.854  Millions
Pro dex Inc   0.26 $ 8.228  Millions$ 31.786  Millions
Genedx Holdings Corp   0.23 $ 52.688  Millions$ 228.017  Millions
Innovage Holding Corp   0.22 $ 63.162  Millions$ 291.141  Millions
Si bone inc   0.21 $ 36.065  Millions$ 169.375  Millions
Procept Biorobotics Corporation  0.18 $ 51.339  Millions$ 280.752  Millions
Precision Optics Corporation Inc   0.17 $ 1.919  Millions$ 11.317  Millions
Irhythm Technologies Inc   0.17 $ 34.950  Millions$ 210.097  Millions
Enovis Corporation  0.14 $ 466.164  Millions$ 3,420.701  Millions
Tactile Systems Technology Inc   0.14 $ 26.176  Millions$ 193.642  Millions
Atricure Inc   0.13 $ 60.593  Millions$ 466.168  Millions
Avanos Medical Inc   0.13 $ 159.400  Millions$ 1,236.300  Millions
Cytosorbents Corporation  0.11 $ 2.543  Millions$ 23.275  Millions
Encision Inc   0.11 $ 0.233  Millions$ 2.193  Millions
Globus Medical Inc   0.10 $ 417.400  Millions$ 3,997.959  Millions
Ufp Technologies Inc   0.10 $ 28.000  Millions$ 286.091  Millions
Edwards Lifesciences Corporation  0.09 $ 597.000  Millions$ 6,719.400  Millions
Escalon Medical Corp   0.08 $ 0.142  Millions$ 1.837  Millions
Intelligent Bio Solutions Inc   0.07 $ 0.231  Millions$ 3.154  Millions
Alpha Tau Medical Ltd   0.07 $ 5.610  Millions$ 84.475  Millions
Biolife Solutions Inc   0.05 $ 18.311  Millions$ 337.663  Millions

Date modified: 2024-02-22T17:14:32+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com